307308-03-8 Usage
Uses
Used in Pharmaceutical Synthesis:
Pyrazolo[1,5-a]pyridine-3-carboxaldehyde, 4,5,6,7-tetrahydro(9CI) is utilized as a building block in the synthesis of various pharmaceuticals and bioactive molecules. Its unique structure allows for the creation of diverse compounds with potential therapeutic effects.
Used in Organic Electronics and Optoelectronics:
Due to its electronic properties, Pyrazolo[1,5-a]pyridine-3-carboxaldehyde, 4,5,6,7-tetrahydro(9CI) has been investigated for its potential use in organic electronic and optoelectronic devices, where it could contribute to the development of advanced materials for these applications.
Used in Antimicrobial Applications:
Pyrazolo[1,5-a]pyridine-3-carboxaldehyde, 4,5,6,7-tetrahydro(9CI) has been studied for its antimicrobial properties, making it a candidate for use in applications requiring the inhibition of microbial growth, such as in the development of new antibiotics or disinfectants.
Used in Anti-inflammatory Applications:
Pyrazolo[1,5-a]pyridine-3-carboxaldehyde, 4,5,6,7-tetrahydro(9CI) has also been explored for its anti-inflammatory potential, suggesting that it could be used in the development of treatments for inflammatory conditions.
Used in Antitumor Applications:
Pyrazolo[1,5-a]pyridine-3-carboxaldehyde, 4,5,6,7-tetrahydro(9CI)'s antitumor properties have been of interest, indicating that it could be employed in the development of new cancer therapies, potentially offering novel treatment options for patients.
Check Digit Verification of cas no
The CAS Registry Mumber 307308-03-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,7,3,0 and 8 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 307308-03:
(8*3)+(7*0)+(6*7)+(5*3)+(4*0)+(3*8)+(2*0)+(1*3)=108
108 % 10 = 8
So 307308-03-8 is a valid CAS Registry Number.
307308-03-8Relevant academic research and scientific papers
IMIDAZOTRIAZINONE COMPOUNDS
-
, (2013/10/08)
The present invention provides imidazotriazinone compounds which are inhibitors of phosphodiesterase 9 and pharmaceutically acceptable salt thereof. The present invention further provides processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of PDE9 associated diseases or disorders in mammals, including humans.
